Announced Mon, 9 Feb · 17:12 IST

Tatva Chintan Pharma Chem Limited has informed the Exchange regarding 'Filing Of Report Under Regulation 7(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015, As Amended (''SEBI Insider Trading Regulations'')'.

Ownership Changes View source PDF

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Tatva Chintan Pharma Chem Limited has submitted a report to the exchange as required under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. This regulation requires designated persons and insiders to disclose their trading in the company's shares within two trading days of the transaction. However, the specific details of the trade, including who traded, the quantity, and the direction (buy or sell), are not included in the headline.

Likely market impact

This is a routine regulatory compliance filing and does not by itself indicate any major corporate action. Shareholders should wait for further details on the nature of the insider transaction to assess any potential impact on stock price or sentiment.